Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
about
D-Penicillamine for preventing retinopathy of prematurity in preterm infantsCopper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stressNeomycin inhibits angiogenin-induced angiogenesisAngiogenesis in the pathogenesis of inflammatory joint and lung diseasesAngiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators.D-Penicillamine administration and the incidence of retinopathy of prematurity.A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates.Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritisA role for angiogenesis in rheumatoid arthritis.D-Penicillamine for preventing retinopathy of prematurity in preterm infants.Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implicationsQuantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging.Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle.Angiogenesis inhibition suppresses collagen arthritis.The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistryCaptopril inhibits angiogenesis and slows the growth of experimental tumors in rats.How to characterize a biological antioxidant.The heat shock protein response and its role in inflammatory disease.Tumour vasculature--a potential therapeutic target.Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.Transgenic mice model of ocular neovascularization driven by vascular endothelial growth factor (VEGF) overexpression.
P2860
Q24198241-C8878451-A89E-4682-BB0A-F967E7E6EC8EQ24291389-744381BF-9C91-4438-9421-102FE0E0CECAQ24324597-AF1D2A65-B30B-4A53-B863-AD65F16C7AF6Q24805418-07DEF1BF-D92A-444E-9189-9A94BE3D0C25Q33245745-E9B3804E-03BB-4C7E-8644-FA2E04CCF29FQ33270825-0874EAE3-8A5A-4247-A8EA-EE7C64865C82Q33369884-D4964D0E-5B4E-498A-800E-0DFFBEFF4C36Q33584025-ED8BA203-D832-4922-9031-FDBB8661AC6EQ33690821-6D4ADE8E-F591-4D62-A8A0-53DFDD53211CQ33907340-00D749BD-C049-4290-9BA8-499A393B763FQ35327839-9858B2EF-37A4-4B9E-B80E-D02AE25F2BAEQ35547725-2E904508-9A32-4016-9EA1-D4DA81B3E8DAQ35800509-EF15D848-4EE7-419B-9560-BAD0C8986BAFQ35994724-4342771B-2E34-4F49-872D-61D863C29BE7Q36231174-D3EC5EE9-F054-48E1-B2B9-76A4EDA61F05Q36598768-DCC3F509-0A48-4A14-9C82-2141A620D502Q37206068-69F54D3A-F41F-4D72-9334-E0D6582C702FQ37358195-5E2135BD-6263-43AA-BA5D-C1992C64FFB1Q37877692-A566C4AF-38CD-415D-BEDB-AA7345F7291CQ37908837-7ABEAE64-0322-4240-BE93-59D80B786894Q40403280-5793B9F1-4B9C-4D3B-AD61-E4323B5EB27FQ42773874-57525DCF-FEEF-48CD-A98A-728AB4B23260Q42838776-BB819E5C-F8E8-4A30-AF22-A081C80F3518
P2860
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@ast
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@en
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@nl
type
label
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@ast
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@en
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@nl
prefLabel
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@ast
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@en
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@nl
P2093
P2860
P356
P1476
Inhibition of human endothelia ...... on in vivo by D-penicillamine.
@en
P2093
P2860
P304
P356
10.1172/JCI113853
P407
P577
1989-01-01T00:00:00Z